When will Compass Pathways submit a NDA for COMP360 psilocybin?
Health & MedicineOne-OffScienceBusiness & Corporate5d
KalshiCheck availabilityKYC requiredVerified resolution dataWell calibratedData quality warningStale data
Data as of Oct 26, 2026, 7:32 AM UTC · policy pm-quality-4
Selected book midpoint
before 2027 · —
Loading selected book…
—
Stored price
before 2027 85.5%Leader of 6 outcomes
before 2027 85.5%Market quality
43 / 100
Low quality24h Volume
$5.3
Open interest
$11.9K
Medium open interestBid / Ask
— / —
before 2027Spread
—
Market data
Updated 1 hour ago
LaggingMar 24, 26, 2:00 PM UTCNov 1, 26, 5:00 AM UTC
Chart and changes show stored historical probabilities, not the selected live book.
Trends
Selected row: book midpoint. Other rows: stored references, possibly normalized; 24h changes use stored history.
before SeptemberLost
before OctoberLost
Venue terms
Source: Kalshi
Informational venue terms only; CoinRithm paper trading uses its own rules.
- Early close:
- Yes
- Settlement timer:
- 30m (informational)
Market depth · before 2027
Loading selected book…
—
Related Markets
Related questions for context, not a comparison of equivalent contracts.
When will the FDA approve Compass Pathways' COMP360 Psilocybin?
KalshiWhich fast food chain in the USA will offer a lab-grown / cultivated meat product first?
Manifold MarketsWhen will I be able to buy cultured meat at a random Whole Foods?
Manifold MarketsWill Tomorrow Bio exist or have continuity with another organisation in 20 years?
Manifold MarketsWill 3 mg THC beverages be federally legal to sell?
KalshiWill Aurelia Song abandon Nectome before 2041?
Manifold MarketsRules
If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Apr 1, 2027, then the market resolves to Yes.
Rules for each outcome
- before 2027
- If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Jan 1, 2027, then the market resolves to Yes.
- before April 2027
- If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Apr 1, 2027, then the market resolves to Yes.
- before December
- If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Dec 1, 2026, then the market resolves to Yes.
- before November
- If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Nov 1, 2026, then the market resolves to Yes.
- before September
- If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Sep 1, 2026, then the market resolves to Yes.
- before October
- If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Oct 1, 2026, then the market resolves to Yes.
